InvestorsHub Logo

wsbc

09/14/18 1:17 PM

#241043 RE: TheDane #241041

Yeah, all good questions for sure.

The company's lack of transparency here isn't making things easier.

I feel like there's a lot of forensic accounting analysis going on around here (on the board) to try to dissect the 10-K, when I guess if we wait for another week or so, we'll hopefully just have the answers we're seeking.

If it's $4m they needed, I agree that it should've been just written into the agreement, unless they're a LOT further along contract-wise with a prospective BP, or unless they have some sort of other product that doesn't require FDA approval (Derm topical or something) that's a spinoff of B, that's ready to roll out EOM. Sell other stuff for other indications that haven't been hyped, generate revenue, ditch Aspire, keep marching... ?

I dunno. Just spitballing here..

Would Aspire have entered into the agreement they made knowing IPIX had that kind of nut to crack? They only got $2 million from Aspire at that time.